Moderna Shares Jump After FDA Approves Phase 2 Trial For Its Coronavirus Vaccine

Plus, stocks are higher on hopes for trade talks between the U.S. and China, weekly jobless claims came in at 3.17 million, luxury department store Neiman Marcus filed for Chapter 11, and Tesla has temporarily halted production at its Shanghai plant. 

Stocks were higher to start Thursday with the Dow rising 285 points, or 1.2%. The S&P 500 added 1.25%, while the Nasdaq gained 1.2%, clawing back its steep losses for the year.

Stocks were boosted this morning by a narrative right out of 2019: hopes for trade talks between the U.S. and China. Top Chinese and U.S. trade negotiators are expected to speak as soon as next week on progress in implementing the phase one trade deal after President Donald Trump threatened to “terminate” the agreement if China isn’t adhering to the terms. “We’re watching the deal very closely,” Trump said. “They understand. They have a deal and hopefully they are going to keep it. They may or they may not, we’ll see.” Chinese Vice Premier Liu He and U.S. trade representative Robert Lighthizer are expected to be on the trade call, which will be the first the two sides speak formally about the agreement since it was signed in January, just before the global coronavirus pandemic hit both economies. 

Unemployment claims continued to swell. 3.17 million Americans filed for unemployment last week, brining the total for the last seven weeks amid the coronavirus shutdown to 33.5 million. According to Pantheon Macroeconomics chief economist Ian Shepherdson, the current pact indicates weekly claims should fall below 1 million by mid-June. “We’re very hopeful that June will see the beginnings of a rebound as states begin to reopen,” Shepherdson said. However, “initial claims are only coming down slowly, and more slowly than we had anticipated previously,” said Michael Gapen, chief U.S. economist at Barclays Plc, in a note. “The trend in claims points to upside risks to the unemployment rate and suggests federal resources in the CARES Act and other legislation have not been fully successful at keeping workers on payrolls.”

Moderna shares are up 7.5% at the time of writing following the company’s announcement that the FDA cleared its coronavirus vaccine for a phase 2 trial. Moderna said it will start the phase 2 trial with 600 participants and is in the process of finalizing plans for a phase 3 trail as early as this summer. “The imminent Phase 2 study start is a crucial step forward as we continue to advance the clinical development of mRNA-1273, our vaccine candidate against SARS-CoV-2,” Moderna CEO Stephane Bancel said in a statement. “With the goal of starting the mRNA-1273 pivotal Phase 3 study early this summer, Moderna is now preparing to potentially have its first [biologics license application] approved as soon as 2021.”

Neiman Marcus became the first department store to file for bankruptcy amid the coronavirus pandemic, and the second household-name retailer to file this week after J.Crew. The luxury department store chain was struggling even before the pandemic as it was overtaken by online rivals and saddled by $4 billion in debt, with those problems exacerbated by the virus outbreak that forced Neiman’s to close its 43 stores and furlough the majority of its 14,000 workers. Neiman Marcus said it has secured $675 million in financing from its creditors to fund operations through bankruptcy, which it expects to emerge from this fall. The chain “has struggled for years to adapt among ongoing secular changes facing the department store sector, a circumstance that has deteriorated because of the operation disruptions from the coronavirus and recessionary conditions,” said S&P analyst Mathew Christy in a recent note.

Tesla shares swooned a bit this morning after reports that the electric car maker has suspended production at its plant near Shanghai. Tesla informed factory workers who were supposed to return to work yesterday after China’s five day Labor Day break, with the holiday being extended to at least May 9. Chinese technology news site 36kr reported that the suspension of operations was due to component shortages, and problems with a crucial piece of manufacturing equipment that is being fixed. With the production halt at its China facility and its Fremont, California plant still closed amid the coronavirus pandemic, Tesla isn’t currently able to produce any vehicles globally. 

Stocks We’re Watching

Axonics Modulation Technologies Inc (NASDAQ: AXNX): Axonics shares gained 10% yesterday after the medical device maker reported a surprise profit in the first quarter. “We are quite proud of this quarter’s exceptional revenue result considering we had only been in the market for two months prior to the start of 2020. Moreover, we believe that this result ranks among the highest revenue total generated in the history of the medical device industry for a company’s first full quarter of sales in the U.S. following FDA approval,” said Axonics CEO Raymond W. Cohen in the company’s earnings release. “The results are a testament to the quality of our 170 person U.S. commercial team and were driven by the overwhelmingly positive response from the SNM implanting community and their patients to the introduction of a bespoke SNM device that is intuitive, fuss-free, long-lived, MRI compatible, safe and clinically effective. This quarter’s results reinforce our confidence that the SNM market is poised for meaningful expansion in the years ahead, driven to a large extent by Axonics’ continuous innovation and commitment to increasing patient awareness. As elective procedures are rescheduled, we expect to be very active in the months ahead as more patients say ‘yes’ to Axonics and SNM therapy. Despite the setback from COVID-19, we remain bullish about our prospects for continued growth in 2020 and beyond.”

 
Trending Ideas

Featured Stocks On The Move

Daily Rundown

Top 3 Stocks in Leading Sectors
  • 3 Software Stocks To Buy Now

    International Business Machines Corporation (IBM) International Business Machines Corporation (IBM) is a global leader in cloud computing, AI, and enterprise software. The company provides IT infrastructure, cybersecurity, and quantum computing... Read More

  • 3 Food Stocks To Buy Now

    The Campbell’s Company (CPB) The Campbell’s Company is a leading producer of packaged foods and beverages, known for its soups, sauces, and snacks. With brands like Campbell’s, Pepperidge Farm, and... Read More

  • 3 Utility Stocks To Buy Now

    IDACORP, Inc. (IDA) IDACORP, Inc. is a utility holding company that provides electricity through its subsidiary, Idaho Power. The company focuses on renewable energy initiatives, grid modernization, and sustainable power... Read More

  • 3 Biotechnology Stocks To Buy Now

    Xeris Biopharma Holdings, Inc. (XERS) Xeris Biopharma Holdings, Inc. is a specialty pharmaceutical company focused on developing and commercializing innovative injectable drug formulations. Its proprietary technology enhances drug stability and... Read More

  • 3 Consumer Service Stocks To Buy Now

    TripAdvisor, Inc. (TRIP) TripAdvisor, Inc. operates the world’s largest travel guidance platform, offering user-generated reviews, price comparisons, and booking services for hotels, attractions, and restaurants worldwide. Chart Wynn Resorts, Limited... Read More

  • 3 Software Stocks To Buy Now

    Udemy, Inc. (UDMY) Udemy, Inc. is an online learning platform offering a vast catalog of courses across various fields. The company connects learners with expert instructors, providing affordable and accessible... Read More

  • 3 Energy Stocks To Buy Now

    Ranger Energy Services, Inc. (RNGR) Ranger Energy Services, Inc. provides well services and support for oil and gas production. The company specializes in high-spec rig solutions, completion services, and workover... Read More

  • 3 Pharmaceutical Stocks To Buy Now

    ACADIA Pharmaceuticals Inc. (ACAD) ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on developing therapies for central nervous system disorders. The company’s lead product, NUPLAZID, is used to treat Parkinson’s... Read More